Delivery Order SPE2DB24D1201-SPE2DR25F8QMM
- Not listed
- The Defense Logistics Agency awarded a $6,530.16 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors, with completion targeted for July 21, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The product will be performed and delivered from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,644.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 25, 2025, with a completion date of July 28, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting the federal government's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.17 for Mounjaro 7.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single shipment of this diabetes medication to support federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,773.80 to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pen injections on August 20, 2025, with completion by August 21, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), represents a non-competitive set-aside award for a pharmaceutical product commonly used in diabetes management. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,932.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This firm fixed-price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025, one day after the award date. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,265.08 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single delivery transaction for this diabetes medication as part of the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,899.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract procures a diabetes medication used across military and federal healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $7,131.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DR25F8QMMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,769.69 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract covers the supply of this diabetes medication, which falls within AmerisourceBergen's broader pharmaceutical distribution portfolio supporting federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated sustained capability to fulfill federal medical supply requirements through open competition and serves as a critical vendor for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 8/22/25 |